GT Biopharma (GTBP) Return on Sales (2010 - 2016)
GT Biopharma (GTBP) posted quarterly Return on Sales of 6.87% for Q1 2016, up 3618.0% year-over-year from 0.18% in Q2 2015, and up 186.42% quarter-over-quarter from 7.95% in Q4 2015.
GT Biopharma (GTBP) Return on Sales (2010 - 2016) Analysis & Trends
GT Biopharma (GTBP) has reported Return on Sales for 7 consecutive years, with 6.87% the latest figure, recorded in Q1 2016.
- In Q1 2016, Return on Sales rose 3618.0% year-over-year to 6.87%; the TTM figure through Mar 2016 stood at 6.87% (down 872.0% YoY), while the FY2015 annual figure was 7.95%, up 45.0% from the prior year.
- Return on Sales climbed to 6.87% in Q1 2016 per GTBP's latest filing, from 7.95% in the prior quarter.
- Across five years, Return on Sales topped out at 13.43% in Q2 2015 and bottomed at 29.31% in Q1 2015.
- Historically, Return on Sales has averaged 4.78% across 5 years, with a median of 0.17% in 2014.
- Annual changes were most pronounced in 2015 — Return on Sales plunged 2914 bps — and 2016, when it jumped 3618 bps.
- GT Biopharma's Return on Sales stood at 0.06% in 2012, then slipped by 8 bps to 0.05% in 2013, then plunged by 405 bps to 0.17% in 2014, then slumped by 4658 bps to 7.95% in 2015, then jumped by 186 bps to 6.87% in 2016.
- Business Quant data shows GTBP's Return on Sales at 6.87% in Q1 2016, 7.95% in Q4 2015, and 5.19% in Q3 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.03 Bn | 131.18 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | 0.00% |
| 4 | Moderna | 57.93 Bn | 52.80 Bn | 52.00 Mn | -0.05% |
| 5 | BeOne Medicines | 41.95 Bn | 36.86 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 0.00% |
| 7 | BioNTech SE | 28.00 Bn | 9.60 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 0.00% |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 0.00% |
| 10 | GT Biopharma | 8.64 Mn | 8.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2016 | 6.87% |
| Dec 31, 2015 | -7.95% |
| Sep 30, 2015 | -5.19% |
| Jun 30, 2015 | 13.43% |
| Mar 31, 2015 | -29.31% |
| Mar 31, 2014 | -0.17% |
| Mar 31, 2013 | 0.05% |
| Dec 31, 2012 | 0.06% |
| Sep 30, 2012 | -0.12% |
| Jun 30, 2012 | -24.08% |
| Mar 31, 2012 | -6.15% |
| Dec 31, 2011 | -3.79% |
| Sep 30, 2011 | 0.12% |
| Jun 30, 2011 | -6.62% |
| Mar 31, 2011 | -0.96% |
| Dec 31, 2010 | -0.60% |